Mangoceuticals, Inc. Announces TV Air Dates for Interview Featuring CEO Jacob Cohen on Fox Business, Bloomberg TV, and Newsmax TV

Dallas, Texas, July 12, 2023 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ:MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing and selling a variety of men’s health and wellness products via a secure telemedicine platform, including its uniquely formulated erectile dysfunction (ED) drug branded “Mango,” is pleased to announce air dates for the first episode of a multi-part TV series on FMW Media’s “New To The Street” business TV show featuring an in-depth interview with Mangoceuticals, Inc.’s CEO, Jacob Cohen.

The interview was filmed at the Nasdaq MarketSite Studio and will air on Fox Business Network, Bloomberg TV (as a sponsored program), and Newsmax TV (through its syndicated and sponsored networks) as follows:

• July 22 at 3:30 p.m. ET on Newsmax TV
• July 24 at 10:30 p.m. PT on Fox Business
• August 5 at 6 p.m. ET on Bloomberg TV
  

Jane King, the host of New To The Street, sat down with Mr. Cohen to discuss Mangoceuticals’ vision, including how the Company identified its market opportunity and how it plans to execute its business plan in strategic planning terms.

In the interview, Mr. Cohen began by noting that the rise of direct-to-consumer telemedicine as an emerging pathway has attracted tremendous interest and the formation of many new businesses focused on selling health and wellness products through expanding telemedicine platforms.

But that the current product offerings amongst the competition in the market lacked innovation. MangoRx is predicated, in part, on stepping into that equation and introducing something capable of capitalizing on the emergence of direct-to-consumer telemedicine platforms while simultaneously disrupting the Men’s Health and Wellness marketplace. He points out that the Company’s first ED product represents an innovation in both formulation and in its sublingual delivery mechanism. He highlights the Company’s innovative formulation and its approach to marketing in the interview as well.

In addition to containing a proven ED pharma compound, Mango contains other ingredients that promote blood flow and intimacy. But it also offers a more efficient delivery mechanism through rapidly dissolved tablets (RDT) absorbed orally.

Mr. Cohen also discusses the Company’s unique marketing concept involving a high degree of overlap between its consumers and its investors, tying together investor relations and product marketing, which promotes additional ROI gains on capital invested in marketing efforts.